UK markets open in 58 minutes

AERI Aug 2022 15.000 put

OPR - OPR Delayed price. Currency in USD
Add to watchlist
7.300.00 (0.00%)
As of 04:25PM EDT. Market open.
Full screen
Previous close7.30
Open7.30
Bid7.50
Ask8.40
Strike15.00
Expiry date2022-08-19
Day's range7.30 - 7.30
Contract rangeN/A
Volume4
Open interest5
  • Zacks

    Roche's (RHHBY) sBLA For Polivy Combo Accepted by FDA

    Roche's (RHHBY) sBLA seeking approval for the use of Polivy in combination with R-CHP for previously untreated diffuse large B-cell lymphoma in adults has been accepted in the United States.

  • Business Wire

    Aerie Pharmaceuticals Announces New Employee Inducement Grant

    DURHAM, N.C., August 15, 2022--Aerie Pharmaceuticals, Inc. (NASDAQ:AERI), a pharmaceutical company focused on the discovery, development, and commercialization of first-in-class ophthalmic therapies for the treatment of patients with open-angle glaucoma, ocular surface diseases and retinal diseases today announced that the compensation committee of Aerie Pharmaceutical’s board of directors granted one new employee an award totaling 16,900 stock options that will vest over 4 years, with 25% vesti

  • Zacks

    Wall Street Analysts See a 75% Upside in Aerie (AERI): Can the Stock Really Move This High?

    The consensus price target hints at a 75.1% upside potential for Aerie (AERI). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.